Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03830866
Title Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA) (CALLA)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca

cervical adenocarcinoma

cervical squamous cell carcinoma



Cisplatin + Durvalumab

Carboplatin + Durvalumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.